Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Day

Showing results (11-20 of 123) with videos related to

Pageof 13
Sort By:
Drug Design, Development and Therapy|November 11, 2017
Guideline development for the management of gout: role of combination therapy with a focus on lesinuradGraeme Jones, Elena Panova, Richard Day
Studies in Health Technology and Informatics|July 22, 2016
A User-Centred Approach to Designing an eTool for Gout ManagementAnna Fernon, Amy Nguyen, Melissa Baysari, et al.
BMJ (Clinical Research Ed.)|December 3, 2011
How clinical and research failures lead to suboptimal prescribing: the example of chronic goutWendy Lipworth, Ian Kerridge, Jonathan Brett, et al.
Journal of the Society for Integrative Oncology|May 30, 2009
Pilot, randomized, modified, double-blind, placebo-controlled trial of acupuncture for cancer-related fatigueJudith Balk, Richard Day, Margaret Rosenzweig, et al.
Annals of the Rheumatic Diseases|February 20, 2016
Allopurinol dose relative to renal function and risk of hypersensitivity reactionsRichard Day, Shuen-Iu Hung, Wen-Hung Chung
The New Zealand Medical Journal|October 25, 2013
Benzbromarone: availability for general prescribing in New Zealand (a response to letters by Dr Lance Gravatt onbenzbromarone)Richard Day, Hugo Lee, Garry Graham, et al.
Neurotoxicology and Teratology|July 9, 2010
Caudate asymmetry: a neurobiological marker of moderate prenatal alcohol exposure in young adultsJennifer Willford, Richard Day, Howard Aizenstein, et al.
Pain Medicine (Malden, Mass.)|July 14, 2010
A risk-benefit assessment of paracetamol (acetaminophen) combined with caffeineHazel Palmer, Garry Graham, Kenneth Williams, et al.
Australian Health Review : a Publication of the Australian Hospital Association|March 5, 2014
Challenges to pharmaceutical policymaking: lessons from Australia's national medicines policyWendy Lipworth, Evan Doran, Ian Kerridge, et al.
BMJ (Clinical Research Ed.)|January 18, 2012
Evidence and desperation in off-label prescribing: recombinant factor VIIaWendy Lipworth, Ian Kerridge, Miles Little, et al.
Pageof 13

Showing results (11-20 of 123) with videos related to

Sort By:
Pageof 13
Drug Design, Development and Therapy|November 11, 2017
Guideline development for the management of gout: role of combination therapy with a focus on lesinuradGraeme Jones, Elena Panova, Richard Day
Studies in Health Technology and Informatics|July 22, 2016
A User-Centred Approach to Designing an eTool for Gout ManagementAnna Fernon, Amy Nguyen, Melissa Baysari, et al.
BMJ (Clinical Research Ed.)|December 3, 2011
How clinical and research failures lead to suboptimal prescribing: the example of chronic goutWendy Lipworth, Ian Kerridge, Jonathan Brett, et al.
Journal of the Society for Integrative Oncology|May 30, 2009
Pilot, randomized, modified, double-blind, placebo-controlled trial of acupuncture for cancer-related fatigueJudith Balk, Richard Day, Margaret Rosenzweig, et al.
Annals of the Rheumatic Diseases|February 20, 2016
Allopurinol dose relative to renal function and risk of hypersensitivity reactionsRichard Day, Shuen-Iu Hung, Wen-Hung Chung
The New Zealand Medical Journal|October 25, 2013
Benzbromarone: availability for general prescribing in New Zealand (a response to letters by Dr Lance Gravatt onbenzbromarone)Richard Day, Hugo Lee, Garry Graham, et al.
Neurotoxicology and Teratology|July 9, 2010
Caudate asymmetry: a neurobiological marker of moderate prenatal alcohol exposure in young adultsJennifer Willford, Richard Day, Howard Aizenstein, et al.
Pain Medicine (Malden, Mass.)|July 14, 2010
A risk-benefit assessment of paracetamol (acetaminophen) combined with caffeineHazel Palmer, Garry Graham, Kenneth Williams, et al.
Australian Health Review : a Publication of the Australian Hospital Association|March 5, 2014
Challenges to pharmaceutical policymaking: lessons from Australia's national medicines policyWendy Lipworth, Evan Doran, Ian Kerridge, et al.
BMJ (Clinical Research Ed.)|January 18, 2012
Evidence and desperation in off-label prescribing: recombinant factor VIIaWendy Lipworth, Ian Kerridge, Miles Little, et al.
Pageof 13